ECSP045074A - HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS - Google Patents

HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS

Info

Publication number
ECSP045074A
ECSP045074A ECSP045074A ECSP045074A EC SP045074 A ECSP045074 A EC SP045074A EC SP045074 A ECSP045074 A EC SP045074A EC SP045074 A ECSP045074 A EC SP045074A
Authority
EC
Ecuador
Prior art keywords
hiv
hydroxypirimidinone
carboxamide
inhibitors
replaced
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP045074 priority Critical patent/ECSP045074A/en
Publication of ECSP045074A publication Critical patent/ECSP045074A/en

Links

Abstract

La presente invención está dirigida a hidroxipirimidinona carboxamidas novedosas. Estos compuestos son útiles en la inhibición de la integrasa de VIH, la prevención de la infección por VIH, el tratamiento de la infección por VIH y en la prevención, tratamiento y retraso de la aparición de SIDA y/o ARC, ya sea como compuestos o sus sales farmacéuticamente aceptables o hidratos (cuando sea apropiado), o como ingredientes de la composición farmacéutica, y sea o no en combinación con otros antivirales de VIH/SIDA, anti-infecciosos, inmunomoduladores, antibióticos o vacunas. Más particularmente, la presente invención incluye un compuesto de la Fórmula (I) cuya descripción de elementos se encuentra en la primera reivindicación.The present invention is directed to novel hydroxypyrimidinone carboxamides. These compounds are useful in inhibiting HIV integrase, preventing HIV infection, treating HIV infection and preventing, treating and delaying the onset of AIDS and / or ARC, either as compounds. or its pharmaceutically acceptable salts or hydrates (when appropriate), or as ingredients of the pharmaceutical composition, whether or not in combination with other HIV / AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. More particularly, the present invention includes a compound of Formula (I) whose description of elements is found in the first claim.

ECSP045074 2004-04-22 2004-04-22 HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS ECSP045074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045074 ECSP045074A (en) 2004-04-22 2004-04-22 HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045074 ECSP045074A (en) 2004-04-22 2004-04-22 HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP045074A true ECSP045074A (en) 2004-05-28

Family

ID=40435097

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045074 ECSP045074A (en) 2004-04-22 2004-04-22 HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP045074A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9296769B2 (en) 2011-08-16 2016-03-29 Gilead Sciences, Inc. Tenofovir alafenamide hemifumarate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9296769B2 (en) 2011-08-16 2016-03-29 Gilead Sciences, Inc. Tenofovir alafenamide hemifumarate

Similar Documents

Publication Publication Date Title
MX2022007527A (en) Kras mutant protein inhibitors.
DK1753723T3 (en) Substituted quinoline derivatives as mitotic kinesin inhibitors
ECSP066826A (en) HIV INTEGRAS INHIBITORS
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
HUP0401740A2 (en) N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase and pharmaceutical compositions containing them
MX2009005881A (en) Non-nucleoside reverse transcriptase inhibitors.
TN2009000243A1 (en) Non-nucleoside reverse transcriptase inhibitors
MXPA05011411A (en) Substituted 1,4-diazepines and uses thereof.
MY152271A (en) Novel compounds that are erk inhibitors
EA200970291A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM
CR9694A (en) HIV REVERSE TRANSCRIPT INHIBITORS
MX2020009234A (en) Heteroaryl compounds as type ii irak inhibitors and uses hereof.
NO20090405L (en) Non-nucleoside reverse transcriptase inhibitors
EA201290976A1 (en) NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
EA201170537A1 (en) HIV INTEGRASE INHIBITORS
PH12019500394A1 (en) Bicyclic nitrogenated heterocyclic compound
CR20220251A (en) New methylquinazolinone derivatives
MY195881A (en) Griseofulvin Compound
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
TW200624429A (en) Novel cysteine protease inhibitors
MX2009010932A (en) Non-nucleoside reverse transcriptase inhibitors.
EP1539714A4 (en) 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
ECSP045074A (en) HYDROXYPIRIMIDINONE CARBOXAMIDE N-REPLACED HIV INTEGRAS INHIBITORS
DOP2006000176A (en) HIV REVERSE TRANSCRIPT INHIBITORS